CSIR Central

Primary role of CYP1B1 in Indian juvenile-onset POAG patients

Metadata of CSIR Papers

View Archive Info
 
 
Field Value
 
Title Primary role of CYP1B1 in Indian juvenile-onset POAG patients
 
Creator Acharya, M
Mookherjee, S
Bhattacharjee, A
Bandyopadhyay, A
Thakur, SKD
Bhaduri, G
Sen, A
Ray, K
 
Subject Biochemistry & Molecular Biology; Ophthalmology
 
Description Purpose: CYP1B1, a member of the cytochrome P450 superfamily of enzymes, has been implicated in primary congenital glaucoma (PCG). Recent studies suggest a role of CYP1B1 in primary open-angle glaucoma (POAG) as a modifier locus. The purpose of the study was to further investigate the potential role of CYP1B1 in POAG patients. Methods: Two hundred unrelated Indian POAG patients and 100 unrelated ethnically matched controls were enrolled in this study. The coding sequence of CYP1B1 was amplified by polymerase chain reaction (PCR) from genomic DNA, followed by direct DNA sequencing to identify the allelic variants. Results: Six mutations were identified in nine patients and none of the controls examined. One novel mutation (R523T) was detected in the homozygous condition while three reported (W57C, E229K, and R368H) and two novel mutations (S515L and D530G) were found in the heterozygous state. The homozygous mutation of a conserved residue, detected in a familial juvenile onset POAG (JOAG) patient (lacking MYOC or OPTN mutations), cosegregated with the disease locus in an autosomal recessive mode of transmission. All the novel mutations (R523T, S515L and D530G) were detected in a region of CYP1B1 that did not harbor any of the 34 point mutations implicated in PCG. In addition, six previously reported (p.R48G, p.A119S, p.V432L, p.D449D, p.N453S, and 372-12C > T in intron 1) and four novel (p.V395V, p.P400P, p.V518A, and c.2016C > G in the 3'-UTR) single nucleotide polymorphism (SNPs) were also observed in POAG patients and controls. Conclusions: Our observation suggests that on rare occasions CYP1B1 may be primarily responsible for JOAG by possible monogenic association, and this observation emphasizes the importance of screening for mutation in this gene of JOAG patients that are determined not to harbor mutations in previously characterized candidate genes and loci for POAG.
 
Publisher MOLECULAR VISIONATLANTAC/O JEFF BOATRIGHT, LAB B, 5500 EMORY EYE CENTER, 1327 CLIFTON RD, N E, ATLANTA, GA 30322 USA
 
Date 2011-09-20T12:12:15Z
2011-09-20T12:12:15Z
2006
 
Type Article
 
Identifier MOLECULAR VISION
1090-0535
http://hdl.handle.net/123456789/14194
 
Language English